Dr. Ginsberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
MC 8409
San Diego, CA 92103Phone+1 619-543-4619
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2012 - 2015- Washington University in St. Louis School of MedicineClass of 2012
Certifications & Licensure
CA State Medical License 2015 - 2026
MO State Medical License 2014 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Clinical Trials
- Phosphate Microvascular Study Start of enrollment: 2019 Jan 01
Publications & Presentations
PubMed
- Catastrophic retinal vascular occlusion and vision loss due to crystal deposition in end-stage kidney disease treated with peritoneal dialysis.Delu Song, Charles Ginsberg, Eric Nudleman, Shyamanga Borooah, Andrew King
American Journal of Ophthalmology Case Reports. 2024-12-01 - Acetazolamide Therapy and Kidney Function in Persons with Nonalbuminuric Diabetes Mellitus Type 1.Charles Ginsberg, Jesse C Seegmiller, Volker Vallon, Sami SeungMi Jin, Robert L Thomas
Journal of the American Society of Nephrology. 2024-10-08 - New Insights into Vitamin D Metabolism in Kidney Disease and Transplant.Charles Ginsberg, Joachim H Ix
American Journal of Kidney Diseases. 2024-10-01
Journal Articles
- PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINTUdayan Y Bhatt, Clinton B Wright, Vasilios Papademetriou, Joachim H Ix, Michael G Shlipak, Alfred K Cheung, Mark J Sarnak, Jing Chen, Charles Ginsberg, Glenn M Chertow..., Journal of the American Society of Nephrology
Press Mentions
Navidea Biopharmaceuticals Reports Second Quarter 2021 Financial ResultsAugust 11th, 2021- Navidea Biopharmaceuticals Announces NIH Grant Award to UC San Diego for Clinical Study Evaluating Tc99m Tilmanocept as a Kidney Imaging AgentMay 11th, 2021
Elevated Phosphate May Be Detrimental Even Without CKDOctober 14th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
